Anne E. Lykkesfeldt

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

Julie Millour, Demetra Constantinidou, Alexandra Stavropoulou et al. · Oncogene · 2010 · 153 citations · Full text

Transcriptional Regulation, Medicine, Genetics +10

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

Birgitte Rasmussen, Meredith M. Regan, Anne E. Lykkesfeldt et al. · The Lancet Oncology · 2007 · 151 citations

Supplementary Results, Endocrine Oncology, Breast Oncology +14

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen et al. · Breast Cancer Research and Treatment · 2008 · 147 citations · Full text

Breast Oncology, Cell Proliferation, Breast Cancer +7

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

Martin J. Larsen, Torben A. Kruse, Qihua Tan et al. · PLoS ONE · 2013 · 114 citations · Full text

Breast Oncology, Engineering, Genetics +18

Effect ofmts1 (S100A4) expression on the progression of human breast cancer cells

Mariam Grigorian, Noona Ambartsumian, Anne E. Lykkesfeldt et al. · International Journal of Cancer · 1996 · 107 citations